Reassessing GSK (LSE:GSK) After 46% Share Price Jump And Pipeline Updates

If you are wondering whether GSK shares still offer value at around £18.86, you are not alone. The stock has been attracting ...
Seeking Alpha

GSK's Q2 Success Amid Challenges: What Investors Need To Know

On July 31, GSK released its financial results for the second quarter of 2024, which again beat analysts' expectations by a wide margin. Under Emma Walmsley's leadership, the company is becoming a ...
Benzinga.com

Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors

GSK stock has climbed 8.20% in the past month, fueled by a £2 billion ($2.5 billion approx.) stock buyback and strong HIV and cancer drug sales. Yet, it still trails peers. Over the past five years, ...
STAT

FDA questions safety of GSK’s multiple myeloma drug

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...